Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancer

By Hasui Y.   Marutsuka K.   Asada Y.   Osada Y.  

Urology, Vol. 47, Iss. 1, 1996-01 ,pp. : 34-37

Elsevier

Access to resources Recommend Favorite

Abnormal Levels of Urokinase Plasminogen Activator Protein and Tissue Plasminogen Activator Activity in Human Aortic Aneurysms

By Falkenberg Mårten   Holmdahl Lena   Tjärnström Johan   Risberg Bo  

European Journal of Surgery, Vol. 167, Iss. 1, 2001-01 ,pp. : 10-14

Informa Healthcare

Access to resources Recommend Favorite

Significance of Coexpression of Urokinase-type Plasminogen Activator, and Matrix Metalloproteinase 3 (Stromelysin) and 9 (Gelatinase B) in Colorectal Carcinoma

By Inuzuka K.   Ogata Y.   Nagase H.   Shirouzu K.  

Journal of Surgical Research, Vol. 93, Iss. 2, 2000-10 ,pp. : 211-218

Academic Press

Access to resources Recommend Favorite

Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder

By Shariat S.F.   Monoski M.A.   Andrews B.   Wheeler T.M.   Lerner S.P.   Slawin K.M.  

Urology, Vol. 61, Iss. 5, 2003-05 ,pp. : 1053-1058

Elsevier

Access to resources Recommend Favorite

Short Chain Fatty Acids Inhibit Human (SW1116) Colon Cancer Cell Invasion by Reducing Urokinase Plasminogen Activator Activity and Stimulating TIMP-1 and TIMP-2 Activities, Rather Than via MMP Modulation

By Emenaker N.J.   Basson M.D.  

Journal of Surgical Research, Vol. 76, Iss. 1, 1998-04 ,pp. : 41-46

Academic Press

Access to resources Recommend Favorite